Among patients with heart failure with preserved ejection fraction, long-term treatment with the medication spironolactone improved left ventricular diastolic function but did not affect maximal exercise capacity, patient symptoms, or quality of life, according to a new study.
Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/C...
Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/C...